RNA

NASDAQStock

Avidity Biosciences, Inc.

$14.61-0.20 (-1.32%)

52-Week Range

$14.54

$72.93

Key Stats

Market Cap

2.3B

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.93

Volume

308.9K

Avg Volume

3.5M

Performance

-80.05%

-79.76%

-63.85%

YTD

-79.83%

-55.41%

-31.99%

-45.19%

Price Chart

ETF Exposure

RNA is held by 58 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
IWV	iShares Russell 3000 ETF	0.00%	3,239	$48K	$17.58B	0.20%
LSLT	Pacer Salt Low truBeta US Market ETF	0.00%	1,085	$79K	$6.8M	0.60%
SCHB	Schwab U.S. Broad Market ETF	0.00%	8,226	$121K	$38.14B	0.03%
SCHK	Schwab 1000 Index ETF	0.00%	1,088	$16K	$4.87B	0.03%
SLT	Pacer Salt High truBeta US Market ETF	0.00%	1,085	$79K	$6.3M	0.60%
TRPL	Pacer Metaurus US Large Cap Dividend Multiplier 300 ETF	0.00%	1,085	$79K	$1.0M	0.79%
VETS	Pacer Military Times Best Employers ETF	0.00%	1,085	$79K	$1.9M	0.60%
VIRS	Pacer BioThreat Strategy ETF	0.00%	1,085	$79K	$3.7M	0.70%

PreviousPage 2 of 2

About RNA ETF Exposure

Avidity Biosciences, Inc. (RNA) is held by 58 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 2.3B, RNA is a widely held institutional stock. The stock currently trades at $14.61. Investors can gain exposure to RNA through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold RNA, sorted by portfolio weight.